Soluble CD30 as an immune risk factor for renal allograft rejection and graft loss

被引:0
|
作者
Kerman, Ronald H. [1 ]
Stepkowski, Stanislaw M. [1 ]
Knight, Richard M. [1 ]
Van Buren, Charles T. [1 ]
Roberts, Laura [1 ]
Boody, Patricia [1 ]
McKissick, Eva [1 ]
Young, Evelin [1 ]
Guidry, Natalie [1 ]
Acorda, Noriel [1 ]
Podder, Hemangshu [1 ]
Kahan, Barry [1 ]
机构
[1] Univ Texas, Sch Med, Houston, TX USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S63 / S63
页数:1
相关论文
共 50 条
  • [21] Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection
    Wang, Dong
    Wu, Guo-Jun
    Wu, Wei-Zhen
    Yang, Shun-Liang
    Chen, Jin-Hua
    Wang, He
    Lin, Wen-Hong
    Wang, Qing-Hua
    Zeng, Zhang-Xin
    Tan, Jian-Ming
    TRANSPLANT IMMUNOLOGY, 2007, 17 (04) : 278 - 282
  • [22] High soluble CD30 serum levels as markers of kidney graft subclinical rejection
    Campos, E. F.
    Grenzi, P.
    Tedesco-Silva, H.
    Felipe, C. R.
    Franco, M.
    Medina-Pestana, J. O.
    Gerbase-DeLima, Maria
    TISSUE ANTIGENS, 2011, 77 (05): : 441 - 442
  • [23] High soluble CD30 serum levels are stable markers of risk for late kidney graft loss
    Grenzi, P.
    Campos, E. F.
    Tedesco-Silva, H.
    Franco, M.
    Medina-Pestana, J. O.
    Gerbase-DeLima, M.
    TISSUE ANTIGENS, 2011, 77 (05): : 456 - 456
  • [24] The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss
    Kozakowski, Nicolas
    Herkner, Harald
    Boehmig, Georg A.
    Regele, Heinz
    Kornauth, Christoph
    Bond, Gregor
    Kikic, Zeljko
    KIDNEY INTERNATIONAL, 2015, 88 (02) : 332 - 340
  • [25] Soluble CD30 as a prognostic factor for outcome following renal transplantation
    Platt, R. E.
    Wu, K. S. T.
    Poole, K.
    Newstead, C. G.
    Clark, B.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (07) : 662 - 663
  • [26] Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival
    Trailin, Andriy V.
    Ostapenko, Tetyana I.
    Nykonenko, Tamara N.
    Nesterenko, Svitlana N.
    Nykonenko, Olexandr S.
    DISEASE MARKERS, 2017, 2017
  • [27] The role of CD30 in skin and heart allograft rejection in the mouse
    Beckmann, J
    Kurts, C
    Klebba, I
    Bayer, B
    Klempnauer, J
    Hoffmann, MW
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 140 - 141
  • [28] Soluble CD30 as a predictor of kidney graft outcome
    Pelzl, S
    Opelz, G
    Wiesel, M
    Schnülle, P
    Schönemann, C
    Döhler, B
    Süsal, C
    TRANSPLANTATION, 2002, 73 (01) : 3 - 6
  • [29] Kidney graft recipients with pretransplantation HLA class I antibodies and high soluble CD30 are at high risk for graft loss
    Rodriguez, Libia M.
    Paris, Sara C.
    Arbelaez, Mario
    Cotes, Jose M.
    Suesal, Caner
    Torres, Yolanda
    Garcia, Luis F.
    HUMAN IMMUNOLOGY, 2007, 68 (08) : 652 - 660
  • [30] Increase in levels of soluble CD30 post - Transplant as a predictor of islet graft rejection.
    Saini, D.
    Ramachandran, S.
    Benshoff, N.
    Liu, W.
    Desai, N.
    Chapman, W.
    Mohanakumar, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 512 - 512